0,615€
0,44%
Echtzeit-Aktienkurs Sino Biopharmaceutical Ltd.
Bid:
Ask:
Echtzeit-Chart der Sino Biopharmaceutical Ltd. Aktie
Börsenkurse Sino Biopharmaceutical Ltd.
| Börse Stuttgart | - | - | - | - | 0,601€ | -1,12% |
| Börse Frankfurt | - | - | - | - | 0,606€ | -1,01% |
| Tradegate | - | - | - | - | 0,597€ | -1,27% |
| gettex | - | - | - | - | 0,607€ | -1,78% |
| Echtzeit USD | - | - | - | - | 0,710$ | -2,57% |
| Lang & Schwarz | - | - | - | - | 0,605€ | -1,79% |
| Echtzeit Euro | - | - | - | - | 0,615€ | 0,44% |
Fundamentaldaten der Sino Biopharmaceutical Ltd. Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 [] | 20,89 Mrd. | 11,58 Mrd. | 9,05 Mrd. | 0,73 | 13,01% | 0,84 | 0,37 |
| 2017 [] | 14,82 Mrd. | 4,27 Mrd. | 2,17 Mrd. | 0,20 | 12,20% | 3,15 | 0,31 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der Sino Biopharmaceutical Ltd. Aktie
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.